PL369520A1 - Tryb dawkowania i środek farmaceutyczny do doraźnej antykoncepcji - Google Patents

Tryb dawkowania i środek farmaceutyczny do doraźnej antykoncepcji

Info

Publication number
PL369520A1
PL369520A1 PL02369520A PL36952002A PL369520A1 PL 369520 A1 PL369520 A1 PL 369520A1 PL 02369520 A PL02369520 A PL 02369520A PL 36952002 A PL36952002 A PL 36952002A PL 369520 A1 PL369520 A1 PL 369520A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
dosage regimen
emergency contraception
contraception
emergency
Prior art date
Application number
PL02369520A
Other languages
English (en)
Other versions
PL206010B1 (pl
Inventor
Look Paul F.A. Van
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt. filed Critical Richter Gedeon Vegyeszeti Gyar Rt.
Publication of PL369520A1 publication Critical patent/PL369520A1/pl
Publication of PL206010B1 publication Critical patent/PL206010B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL369520A 2001-11-27 2002-11-26 Środek farmaceutyczny do antykoncepcji doraźnej zawierający lewonorgestrel i zastosowanie lewonorgestrelu PL206010B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (2)

Publication Number Publication Date
PL369520A1 true PL369520A1 (pl) 2005-04-18
PL206010B1 PL206010B1 (pl) 2010-06-30

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369520A PL206010B1 (pl) 2001-11-27 2002-11-26 Środek farmaceutyczny do antykoncepcji doraźnej zawierający lewonorgestrel i zastosowanie lewonorgestrelu

Country Status (33)

Country Link
US (1) US20050288264A2 (pl)
EP (1) EP1448207B1 (pl)
JP (1) JP2005516904A (pl)
KR (1) KR100908161B1 (pl)
CN (1) CN1551774A (pl)
AP (1) AP1849A (pl)
AT (1) ATE293978T1 (pl)
AU (1) AU2002347401A1 (pl)
BR (1) BR0210595A (pl)
CA (1) CA2450359C (pl)
DE (1) DE60203929T2 (pl)
DK (1) DK1448207T3 (pl)
EA (1) EA006545B1 (pl)
EC (1) ECSP045171A (pl)
ES (1) ES2239727T3 (pl)
GE (1) GEP20063882B (pl)
HR (1) HRP20040584B1 (pl)
HU (1) HU227198B1 (pl)
IL (1) IL159394A0 (pl)
IS (1) IS2691B (pl)
MA (1) MA27076A1 (pl)
MX (1) MXPA04005104A (pl)
NO (1) NO333984B1 (pl)
NZ (1) NZ530056A (pl)
OA (1) OA12730A (pl)
PL (1) PL206010B1 (pl)
PT (1) PT1448207E (pl)
RS (1) RS50768B (pl)
SI (1) SI1448207T1 (pl)
TN (1) TNSN04048A1 (pl)
UA (1) UA79942C2 (pl)
WO (1) WO2003045397A1 (pl)
ZA (1) ZA200404114B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
CN102458386B (zh) * 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) * 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
EP2999469A1 (de) 2013-05-23 2016-03-30 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
KR100908161B1 (ko) 2009-07-16
BR0210595A (pt) 2004-06-08
DE60203929D1 (de) 2005-06-02
RS50768B (sr) 2010-08-31
PL206010B1 (pl) 2010-06-30
PT1448207E (pt) 2005-08-31
IS2691B (is) 2010-10-15
HUP0105173A2 (hu) 2003-08-28
MXPA04005104A (es) 2004-08-19
CA2450359A1 (en) 2003-06-05
HUP0105173D0 (en) 2002-02-28
EP1448207A1 (en) 2004-08-25
AU2002347401A1 (en) 2003-06-10
US20050288264A2 (en) 2005-12-29
NZ530056A (en) 2005-02-25
ECSP045171A (es) 2004-08-27
DE60203929T2 (de) 2006-01-19
EA200400731A1 (ru) 2004-12-30
JP2005516904A (ja) 2005-06-09
DK1448207T3 (da) 2005-06-27
EP1448207B1 (en) 2005-04-27
RS4204A (sr) 2007-02-05
IS7065A (is) 2003-12-05
CA2450359C (en) 2011-05-10
HU227198B1 (en) 2010-10-28
TNSN04048A1 (en) 2006-06-01
AP2004003046A0 (en) 2004-06-30
WO2003045397A1 (en) 2003-06-05
IL159394A0 (en) 2004-06-01
EA006545B1 (ru) 2006-02-24
ZA200404114B (en) 2005-10-26
HUP0105173A3 (en) 2004-03-29
GEP20063882B (en) 2006-07-25
AP1849A (en) 2008-05-23
CN1551774A (zh) 2004-12-01
UA79942C2 (en) 2007-08-10
ATE293978T1 (de) 2005-05-15
HRP20040584A2 (en) 2005-02-28
ES2239727T3 (es) 2005-10-01
HRP20040584B1 (en) 2012-11-30
SI1448207T1 (en) 2005-10-31
NO333984B1 (no) 2013-11-04
OA12730A (fr) 2006-06-28
MA27076A1 (fr) 2004-12-20
NO20041607L (no) 2004-04-20
US20050032755A1 (en) 2005-02-10
KR20040066088A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
HUP0105173D0 (en) Dosage regimen and pharmaceutical composition for emergency contraception
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
GB0117618D0 (en) Pharmaceutical dosage form
HUP0400784A3 (en) Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
GB0117619D0 (en) Pharmaceutical dosage form
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
HUP0303998A3 (en) Phthalazinones derivatives and pharmaceutical compositions containing them
EP1398040A4 (en) MEDICAL COMPOSITION
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0500638A3 (en) Flashmelt oral dosage formulation
IL145188A0 (en) Processes for making pharmaceutical oral ecb formulations and compositions
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
IL153487A0 (en) Pharmaceutical compositions and methods for use
IL153897A0 (en) Pharmaceutical compositions and methods for use
HUP0303379A3 (en) Acid-sensitive compounds, use thereof and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
IL162497A0 (en) Benzhydryl derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SI1215213T1 (sl) Biciklicni derivati amino-pirazonov, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Legal Events

Date Code Title Description
RECP Rectifications of patent specification